Frontiers in Immunology (Oct 2022)

The beneficial effects of Lacticaseibacillus casei on the small intestine and colon of Swiss mice against the deleterious effects of 5-fluorouracil

  • Stphannie Jamyla de Araújo Barbosa,
  • Maisie Mitchele Barbosa Oliveira,
  • Susana Barbosa Ribeiro,
  • Caroline Addison Carvalho Xavier de Medeiros,
  • Caroline Addison Carvalho Xavier de Medeiros,
  • Maria Laura de Souza Lima,
  • Gerlane Coelho Bernardo Guerra,
  • Gerlane Coelho Bernardo Guerra,
  • Raimundo Fernandes de Araújo Júnior,
  • Raimundo Fernandes de Araújo Júnior,
  • Francisco Caninde de Sousa Junior,
  • Agnes Andrade Martins,
  • Daniel Felipe Fernandes Paiva,
  • Raphael Victor Silva Andrade,
  • Conceição S. Martins Rebouças,
  • Gerly Anne de Castro Brito,
  • Renata Ferreira de Carvalho Leitâo,
  • Aurigena Antunes de Araújo,
  • Aurigena Antunes de Araújo

DOI
https://doi.org/10.3389/fimmu.2022.954885
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundIntestinal mucositis is one of the most common and important side effects of 5-fluorouracil (5-FU). Currently, there are still no specific and effective protocols for its prevention and treatment. The aim of the present study was to evaluate the effect of oral administration of Lacticaseibacillus casei (L. casei) on the progression of 5-FU-induced intestinal mucositis. Methods: L. casei (1x109 CFU/ml) or saline was orally administered to Swiss mice, beginning 15 days before intestinal mucositis induction by single intraperitoneal 5-FU administration (450 mg/kg). Body weight, number of peripheral leukocytes and fecal lactic acid bacteria were monitored. After euthanasia, on day 18, tissue samples from colon and each small intestine segment were collected for histopathology. Jejunal tissues were collected and evaluated for iNOS and TNF-alpha immunoexpression, IL-1-beta, IL-6 and TNF-alpha levels, malonaldehyde (MDA) accumulation, invertase activity and factor nuclear kappa B (NFkB-P65) gene expression, toll like receptor-4 (TLR-4), mucin-2 (MUC-2), occludin and zonula occludens-1 (ZO-1).ResultsThe positive impact of L. casei on 5-FU-induced leukopenia was observed, but not on 5-FU-induced weight loss in mice. L. casei reduced 5-FU-induced inflammation in the colon and small intestine (p<0.05). Decreased TNF-α, IL-1β, IL-6 (p<0.05) and MDA (p<0.05) levels, as well as decreased iNOS and TNF-alpha protein expressions (p<0.05) were found in the jejunum from L casei group. In addition, L-casei down-regulated NFKB-P65 (p<0.05) and TLR-4 (p<0.05) gene expressions and up-regulated MUC-2 and mucosal barrier proteins occludin and ZO-1 gene expressions (p<0.05). Furthermore, greater lactic acid bacteria population (p<0.05) was found in the L. casei group when compared to control groups.ConclusionOral L. casei administration can protect the intestine of Swiss mice from 5-FU-induced intestinal mucositis, thus contributing to overall health.

Keywords